United States · FDA National Drug Code directory

Losartan potassium

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
33342-045_81824d1f-61f4-457c-8723-cd43d5429029
Product NDC
33342-045
Form
TABLET, FILM COATED
Composition / generic term
Losartan potassium
Labeler
Macleods Pharmaceuticals Limited
Marketing category
ANDA
Marketing start / end (source format)
20120601
Source listing expiry
20261231

Source-listed ingredients

  • LOSARTAN POTASSIUM — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (33342-045-07) · 33342-045-07
  • 90 TABLET, FILM COATED in 1 BOTTLE (33342-045-10) · 33342-045-10
  • 10 BLISTER PACK in 1 CARTON (33342-045-12) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 33342-045-12
  • 1000 TABLET, FILM COATED in 1 BOTTLE (33342-045-44) · 33342-045-44

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →